Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA, Transfer | 75 | 2024 | 159 | 17.690 |
Why?
|
RNA Processing, Post-Transcriptional | 29 | 2024 | 111 | 7.490 |
Why?
|
Adenosine | 27 | 2024 | 237 | 6.530 |
Why?
|
RNA | 36 | 2024 | 578 | 5.990 |
Why?
|
RNA, Messenger | 30 | 2024 | 2011 | 5.010 |
Why?
|
Protein Biosynthesis | 34 | 2024 | 388 | 5.000 |
Why?
|
RNA, Catalytic | 36 | 2006 | 131 | 4.900 |
Why?
|
Nucleic Acid Conformation | 50 | 2024 | 339 | 4.450 |
Why?
|
RNA, Long Noncoding | 11 | 2021 | 117 | 3.970 |
Why?
|
Pseudouridine | 8 | 2022 | 20 | 3.600 |
Why?
|
Bacillus subtilis | 30 | 2018 | 89 | 3.410 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2023 | 481 | 3.280 |
Why?
|
Endoribonucleases | 25 | 2003 | 92 | 3.090 |
Why?
|
RNA, Bacterial | 26 | 2024 | 111 | 3.060 |
Why?
|
Nucleoside Q | 6 | 2022 | 8 | 2.720 |
Why?
|
Transfer RNA Aminoacylation | 10 | 2020 | 19 | 2.620 |
Why?
|
Escherichia coli | 17 | 2024 | 605 | 2.400 |
Why?
|
Anticodon | 11 | 2022 | 19 | 2.250 |
Why?
|
Amino Acids | 11 | 2023 | 245 | 2.210 |
Why?
|
Methionine | 6 | 2017 | 65 | 2.190 |
Why?
|
RNA-Binding Proteins | 11 | 2020 | 258 | 2.050 |
Why?
|
Escherichia coli Proteins | 10 | 2024 | 183 | 2.010 |
Why?
|
Ribonuclease P | 36 | 2010 | 54 | 2.010 |
Why?
|
HEK293 Cells | 23 | 2021 | 638 | 1.970 |
Why?
|
Base Sequence | 52 | 2023 | 2326 | 1.900 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2024 | 35 | 1.810 |
Why?
|
RNA Stability | 10 | 2024 | 89 | 1.800 |
Why?
|
RNA Precursors | 14 | 2019 | 71 | 1.770 |
Why?
|
Codon | 14 | 2023 | 122 | 1.730 |
Why?
|
Transcriptome | 11 | 2024 | 627 | 1.710 |
Why?
|
Stress, Physiological | 6 | 2018 | 229 | 1.620 |
Why?
|
Transcription, Genetic | 11 | 2019 | 1155 | 1.560 |
Why?
|
MicroRNAs | 3 | 2022 | 550 | 1.490 |
Why?
|
HeLa Cells | 21 | 2021 | 511 | 1.490 |
Why?
|
Microbiota | 5 | 2024 | 398 | 1.390 |
Why?
|
Molecular Sequence Data | 40 | 2016 | 3026 | 1.370 |
Why?
|
Methylation | 14 | 2024 | 268 | 1.230 |
Why?
|
RNA, Transfer, Amino Acyl | 4 | 2017 | 10 | 1.210 |
Why?
|
Humans | 105 | 2024 | 88875 | 1.200 |
Why?
|
Oligonucleotide Array Sequence Analysis | 9 | 2016 | 695 | 1.140 |
Why?
|
Saccharomyces cerevisiae | 13 | 2023 | 439 | 1.130 |
Why?
|
Substrate Specificity | 25 | 2016 | 351 | 1.120 |
Why?
|
Models, Molecular | 22 | 2017 | 1294 | 1.060 |
Why?
|
Genetic Code | 6 | 2017 | 25 | 1.040 |
Why?
|
Adaptation, Biological | 2 | 2016 | 85 | 1.040 |
Why?
|
RNA, Transfer, Phe | 12 | 2010 | 18 | 1.040 |
Why?
|
Methyltransferases | 6 | 2020 | 192 | 1.030 |
Why?
|
Sequence Analysis, RNA | 9 | 2024 | 232 | 1.010 |
Why?
|
Amino Acyl-tRNA Synthetases | 5 | 2020 | 14 | 0.980 |
Why?
|
Streptomyces | 1 | 2024 | 21 | 0.960 |
Why?
|
Aflatoxin B1 | 1 | 2024 | 9 | 0.960 |
Why?
|
Animals | 47 | 2024 | 27274 | 0.960 |
Why?
|
Arachis | 1 | 2024 | 11 | 0.950 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 92 | 0.910 |
Why?
|
RNA, Ribosomal | 3 | 2019 | 64 | 0.890 |
Why?
|
Milk | 1 | 2023 | 53 | 0.880 |
Why?
|
Nanopores | 2 | 2024 | 7 | 0.870 |
Why?
|
Epigenesis, Genetic | 4 | 2016 | 504 | 0.840 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2024 | 282 | 0.840 |
Why?
|
Mutation | 15 | 2023 | 4121 | 0.830 |
Why?
|
Mutation, Missense | 1 | 2023 | 277 | 0.820 |
Why?
|
RNA Folding | 2 | 2012 | 7 | 0.810 |
Why?
|
5-Methylcytosine | 3 | 2020 | 117 | 0.800 |
Why?
|
Interferons | 2 | 2021 | 124 | 0.790 |
Why?
|
Diamines | 1 | 2021 | 11 | 0.790 |
Why?
|
AlkB Enzymes | 2 | 2021 | 3 | 0.780 |
Why?
|
Directed Molecular Evolution | 1 | 2021 | 20 | 0.760 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 2549 | 0.750 |
Why?
|
Histone Deacetylases | 1 | 2021 | 70 | 0.750 |
Why?
|
Proteins | 6 | 2017 | 786 | 0.740 |
Why?
|
Mixed Function Oxygenases | 1 | 2021 | 69 | 0.740 |
Why?
|
Leukemia Virus, Murine | 1 | 2020 | 18 | 0.730 |
Why?
|
Gels | 1 | 2020 | 49 | 0.720 |
Why?
|
Nucleic Acid Hybridization | 6 | 2010 | 243 | 0.710 |
Why?
|
Protein Binding | 15 | 2021 | 1484 | 0.700 |
Why?
|
Cochlear Implantation | 5 | 2023 | 33 | 0.690 |
Why?
|
RNA, Transfer, Amino Acid-Specific | 2 | 2016 | 2 | 0.650 |
Why?
|
Gene Expression Regulation | 7 | 2021 | 1974 | 0.640 |
Why?
|
RNA, Transfer, Met | 2 | 2015 | 6 | 0.630 |
Why?
|
Magnesium | 13 | 2008 | 178 | 0.620 |
Why?
|
Guanosine | 2 | 2021 | 30 | 0.620 |
Why?
|
Kinetics | 19 | 2014 | 1527 | 0.610 |
Why?
|
Peptide Chain Initiation, Translational | 4 | 2016 | 18 | 0.600 |
Why?
|
Binding Sites | 13 | 2021 | 1113 | 0.600 |
Why?
|
Mice | 23 | 2024 | 11722 | 0.600 |
Why?
|
Fluorescent Dyes | 3 | 2016 | 243 | 0.580 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 602 | 0.570 |
Why?
|
Aptamers, Nucleotide | 2 | 2018 | 23 | 0.560 |
Why?
|
Neoplasms | 5 | 2024 | 3020 | 0.560 |
Why?
|
Microarray Analysis | 1 | 2016 | 96 | 0.550 |
Why?
|
Cochlear Implants | 3 | 2023 | 35 | 0.550 |
Why?
|
Gene Library | 2 | 2015 | 133 | 0.550 |
Why?
|
Oxidative Stress | 4 | 2013 | 456 | 0.550 |
Why?
|
Methionine-tRNA Ligase | 5 | 2017 | 8 | 0.540 |
Why?
|
Protein Folding | 6 | 2007 | 287 | 0.540 |
Why?
|
Chromatography, Thin Layer | 1 | 2016 | 32 | 0.540 |
Why?
|
Aeropyrum | 1 | 2015 | 2 | 0.540 |
Why?
|
Archaeal Proteins | 1 | 2015 | 18 | 0.530 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 23 | 0.530 |
Why?
|
Cell Line | 9 | 2024 | 2494 | 0.520 |
Why?
|
Ribosomes | 5 | 2017 | 114 | 0.510 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2015 | 3 | 0.510 |
Why?
|
Prions | 2 | 2005 | 54 | 0.500 |
Why?
|
Gastrointestinal Microbiome | 2 | 2024 | 501 | 0.500 |
Why?
|
Gene Expression Regulation, Bacterial | 4 | 2012 | 213 | 0.490 |
Why?
|
Temperature | 2 | 2015 | 400 | 0.490 |
Why?
|
Acylation | 4 | 2018 | 40 | 0.480 |
Why?
|
Breast Neoplasms | 4 | 2013 | 2991 | 0.480 |
Why?
|
DNA, Complementary | 4 | 2021 | 392 | 0.480 |
Why?
|
RNA, Untranslated | 3 | 2018 | 65 | 0.470 |
Why?
|
Structure-Activity Relationship | 7 | 2021 | 411 | 0.470 |
Why?
|
Reverse Transcription | 4 | 2019 | 14 | 0.460 |
Why?
|
Aminoacylation | 4 | 2023 | 6 | 0.460 |
Why?
|
Discriminant Analysis | 2 | 2024 | 67 | 0.460 |
Why?
|
Least-Squares Analysis | 2 | 2024 | 48 | 0.460 |
Why?
|
Genomics | 2 | 2018 | 751 | 0.460 |
Why?
|
Food Contamination | 2 | 2024 | 32 | 0.460 |
Why?
|
5' Untranslated Regions | 2 | 2016 | 51 | 0.440 |
Why?
|
Staining and Labeling | 1 | 2013 | 168 | 0.440 |
Why?
|
Saccharomyces cerevisiae Proteins | 5 | 2015 | 285 | 0.430 |
Why?
|
RNA, Transfer, Ser | 1 | 2012 | 2 | 0.430 |
Why?
|
Glycosylation | 3 | 2021 | 128 | 0.430 |
Why?
|
Protein Conformation | 5 | 2011 | 885 | 0.410 |
Why?
|
Riboswitch | 1 | 2012 | 6 | 0.410 |
Why?
|
Aspartate-tRNA Ligase | 1 | 2011 | 1 | 0.400 |
Why?
|
RNA, Transfer, Asp | 1 | 2011 | 1 | 0.400 |
Why?
|
Codon, Nonsense | 1 | 2012 | 44 | 0.400 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2012 | 54 | 0.400 |
Why?
|
Alu Elements | 1 | 2011 | 15 | 0.390 |
Why?
|
3' Untranslated Regions | 1 | 2011 | 94 | 0.390 |
Why?
|
Thermodynamics | 13 | 2008 | 310 | 0.380 |
Why?
|
Circadian Clocks | 2 | 2022 | 59 | 0.380 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 314 | 0.370 |
Why?
|
Catalysis | 11 | 2010 | 205 | 0.370 |
Why?
|
Apoptosis | 6 | 2021 | 1715 | 0.370 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 169 | 0.370 |
Why?
|
Charcot-Marie-Tooth Disease | 2 | 2021 | 6 | 0.370 |
Why?
|
Genome | 4 | 2012 | 386 | 0.360 |
Why?
|
Cecum | 3 | 2024 | 69 | 0.360 |
Why?
|
HIV-1 | 4 | 2020 | 165 | 0.350 |
Why?
|
Oligonucleotides | 2 | 2009 | 92 | 0.350 |
Why?
|
MCF-7 Cells | 2 | 2020 | 114 | 0.340 |
Why?
|
Cluster Analysis | 2 | 2023 | 371 | 0.330 |
Why?
|
Proteasome Inhibitors | 1 | 2009 | 52 | 0.330 |
Why?
|
Boronic Acids | 1 | 2009 | 56 | 0.330 |
Why?
|
Catalytic Domain | 8 | 2015 | 156 | 0.330 |
Why?
|
Protease Inhibitors | 1 | 2009 | 73 | 0.330 |
Why?
|
Mitochondria | 4 | 2021 | 551 | 0.330 |
Why?
|
Water Pollutants, Chemical | 2 | 2020 | 135 | 0.330 |
Why?
|
Alternative Splicing | 4 | 2019 | 210 | 0.330 |
Why?
|
DNA-Directed RNA Polymerases | 2 | 2009 | 103 | 0.330 |
Why?
|
PrPSc Proteins | 2 | 2005 | 22 | 0.330 |
Why?
|
Genome, Human | 1 | 2013 | 767 | 0.320 |
Why?
|
Sequence Alignment | 3 | 2018 | 353 | 0.320 |
Why?
|
Pyrazines | 1 | 2009 | 94 | 0.320 |
Why?
|
Bacteria | 3 | 2022 | 472 | 0.320 |
Why?
|
Speech Perception | 2 | 2022 | 71 | 0.320 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2019 | 19 | 0.320 |
Why?
|
Virus Replication | 3 | 2020 | 319 | 0.320 |
Why?
|
Stomach Neoplasms | 3 | 2023 | 281 | 0.310 |
Why?
|
Genome, Fungal | 2 | 2023 | 33 | 0.310 |
Why?
|
DNA Methylation | 3 | 2021 | 657 | 0.310 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 1428 | 0.310 |
Why?
|
RNA, Fungal | 4 | 2007 | 42 | 0.310 |
Why?
|
Urea | 7 | 2001 | 58 | 0.310 |
Why?
|
Ribonuclease, Pancreatic | 4 | 2018 | 24 | 0.300 |
Why?
|
Organ Specificity | 2 | 2016 | 272 | 0.300 |
Why?
|
Immunity, Innate | 2 | 2012 | 428 | 0.290 |
Why?
|
Algorithms | 1 | 2015 | 1870 | 0.290 |
Why?
|
Models, Chemical | 7 | 2007 | 178 | 0.280 |
Why?
|
Models, Biological | 3 | 2011 | 1763 | 0.280 |
Why?
|
RNA Cleavage | 2 | 2018 | 7 | 0.280 |
Why?
|
Cell Proliferation | 6 | 2021 | 1649 | 0.280 |
Why?
|
Genetic Variation | 3 | 2023 | 1371 | 0.280 |
Why?
|
Mammals | 3 | 2022 | 235 | 0.270 |
Why?
|
RNA, Viral | 3 | 2020 | 314 | 0.270 |
Why?
|
Genetic Techniques | 1 | 2006 | 73 | 0.270 |
Why?
|
Ribonucleoproteins | 3 | 2014 | 38 | 0.270 |
Why?
|
Reactive Oxygen Species | 2 | 2024 | 487 | 0.270 |
Why?
|
Holoenzymes | 6 | 2010 | 10 | 0.260 |
Why?
|
Nucleotide Motifs | 3 | 2015 | 48 | 0.260 |
Why?
|
Phylogeny | 8 | 2017 | 1179 | 0.260 |
Why?
|
Amino Acid Sequence | 4 | 2019 | 2061 | 0.260 |
Why?
|
Cell Nucleus | 4 | 2013 | 598 | 0.250 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 783 | 0.250 |
Why?
|
Evolution, Molecular | 5 | 2023 | 839 | 0.250 |
Why?
|
Multiple Myeloma | 1 | 2009 | 330 | 0.250 |
Why?
|
Computational Biology | 2 | 2022 | 542 | 0.250 |
Why?
|
Gallic Acid | 1 | 2024 | 7 | 0.250 |
Why?
|
Prion Diseases | 1 | 2005 | 35 | 0.240 |
Why?
|
Models, Genetic | 5 | 2017 | 944 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 374 | 0.240 |
Why?
|
DNA | 3 | 2021 | 1307 | 0.240 |
Why?
|
Drosophila | 2 | 2021 | 512 | 0.240 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 2 | 2015 | 18 | 0.240 |
Why?
|
Glutathione | 1 | 2024 | 108 | 0.240 |
Why?
|
Copper | 1 | 2024 | 76 | 0.230 |
Why?
|
Peptide Elongation Factors | 2 | 2005 | 28 | 0.230 |
Why?
|
Calibration | 1 | 2024 | 104 | 0.230 |
Why?
|
Transcription Factors | 3 | 2020 | 1650 | 0.230 |
Why?
|
Hydroxyl Radical | 6 | 2002 | 35 | 0.230 |
Why?
|
Albuminuria | 1 | 2024 | 48 | 0.230 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 2023 | 37 | 0.230 |
Why?
|
Evodia | 1 | 2023 | 1 | 0.230 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 66 | 0.230 |
Why?
|
Drug Design | 2 | 2021 | 124 | 0.230 |
Why?
|
Pancreatic Diseases | 1 | 2023 | 52 | 0.230 |
Why?
|
Plants, Medicinal | 1 | 2023 | 42 | 0.230 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2023 | 615 | 0.230 |
Why?
|
Base Pairing | 3 | 2016 | 55 | 0.220 |
Why?
|
Circular Dichroism | 9 | 2010 | 117 | 0.220 |
Why?
|
Nutrition Surveys | 1 | 2024 | 109 | 0.220 |
Why?
|
Bacterial Proteins | 5 | 2013 | 886 | 0.220 |
Why?
|
Dysbiosis | 1 | 2024 | 77 | 0.220 |
Why?
|
Testosterone | 2 | 2022 | 275 | 0.220 |
Why?
|
Inverted Repeat Sequences | 2 | 2013 | 9 | 0.220 |
Why?
|
Periodic Acid | 1 | 2022 | 4 | 0.220 |
Why?
|
Plasmodium yoelii | 1 | 2022 | 4 | 0.220 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 1113 | 0.210 |
Why?
|
Sulfur | 1 | 2022 | 29 | 0.210 |
Why?
|
Malaria | 1 | 2022 | 23 | 0.210 |
Why?
|
Ecology | 1 | 2023 | 74 | 0.210 |
Why?
|
Leydig Cells | 1 | 2022 | 11 | 0.210 |
Why?
|
Powders | 1 | 2023 | 77 | 0.210 |
Why?
|
Intrinsically Disordered Proteins | 1 | 2022 | 10 | 0.210 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 1667 | 0.210 |
Why?
|
Nuclear Proteins | 2 | 2020 | 725 | 0.200 |
Why?
|
Codon, Terminator | 2 | 2013 | 22 | 0.200 |
Why?
|
Gastrointestinal Diseases | 1 | 2023 | 150 | 0.200 |
Why?
|
Hydrolysis | 5 | 2001 | 141 | 0.200 |
Why?
|
Regulon | 1 | 2021 | 17 | 0.200 |
Why?
|
Ossicular Prosthesis | 1 | 2021 | 5 | 0.200 |
Why?
|
Ossicular Replacement | 1 | 2021 | 6 | 0.200 |
Why?
|
Thyroid Hormones | 1 | 2024 | 328 | 0.190 |
Why?
|
Alanine-tRNA Ligase | 1 | 2021 | 1 | 0.190 |
Why?
|
Neuropilin-1 | 1 | 2021 | 14 | 0.190 |
Why?
|
Lead | 1 | 2001 | 26 | 0.190 |
Why?
|
Mutagenesis | 3 | 2013 | 202 | 0.190 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2021 | 78 | 0.190 |
Why?
|
Protein Transport | 2 | 2015 | 421 | 0.190 |
Why?
|
Fluorometry | 1 | 2021 | 30 | 0.190 |
Why?
|
Recidivism | 1 | 2021 | 2 | 0.190 |
Why?
|
Mastoidectomy | 1 | 2021 | 3 | 0.190 |
Why?
|
Cell Cycle Checkpoints | 1 | 2021 | 66 | 0.190 |
Why?
|
Gastroscopy | 1 | 2021 | 25 | 0.190 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 2021 | 8 | 0.190 |
Why?
|
Cholesteatoma | 1 | 2021 | 7 | 0.190 |
Why?
|
Biochemistry | 1 | 2001 | 28 | 0.190 |
Why?
|
Magnets | 1 | 2021 | 14 | 0.190 |
Why?
|
Conservative Treatment | 1 | 2021 | 20 | 0.190 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 2018 | 16 | 0.190 |
Why?
|
Water Purification | 1 | 2020 | 3 | 0.190 |
Why?
|
RNA, Transfer, Lys | 2 | 2018 | 3 | 0.190 |
Why?
|
Polyphenols | 1 | 2020 | 13 | 0.190 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2020 | 16 | 0.180 |
Why?
|
Emergency Treatment | 1 | 2021 | 44 | 0.180 |
Why?
|
Alanine | 2 | 2020 | 83 | 0.180 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2009 | 283 | 0.180 |
Why?
|
Protein Structure, Tertiary | 4 | 2011 | 740 | 0.180 |
Why?
|
tRNA Methyltransferases | 3 | 2024 | 14 | 0.180 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 127 | 0.180 |
Why?
|
Bacteroidetes | 2 | 2018 | 39 | 0.180 |
Why?
|
Abdomen | 1 | 2021 | 122 | 0.180 |
Why?
|
Suppuration | 1 | 2020 | 9 | 0.180 |
Why?
|
Hydro-Lyases | 1 | 2020 | 6 | 0.180 |
Why?
|
HIV Protease | 1 | 2020 | 10 | 0.180 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 159 | 0.180 |
Why?
|
NIH 3T3 Cells | 1 | 2020 | 109 | 0.180 |
Why?
|
Genome, Viral | 1 | 2020 | 79 | 0.180 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 269 | 0.180 |
Why?
|
RNA Editing | 1 | 2020 | 35 | 0.180 |
Why?
|
Foreign Bodies | 1 | 2021 | 66 | 0.180 |
Why?
|
Bromates | 1 | 2019 | 1 | 0.180 |
Why?
|
Retroviridae | 1 | 2020 | 79 | 0.180 |
Why?
|
Environmental Pollutants | 1 | 2020 | 51 | 0.180 |
Why?
|
Phosphorylation | 7 | 2013 | 1128 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2022 | 332 | 0.170 |
Why?
|
Polybrominated Biphenyls | 1 | 2019 | 5 | 0.170 |
Why?
|
Histidine-tRNA Ligase | 1 | 2019 | 1 | 0.170 |
Why?
|
Sodium | 1 | 2001 | 330 | 0.170 |
Why?
|
Genetics, Population | 1 | 2023 | 404 | 0.170 |
Why?
|
Caenorhabditis elegans | 1 | 2021 | 230 | 0.170 |
Why?
|
Brain | 4 | 2024 | 2269 | 0.170 |
Why?
|
Eukaryotic Initiation Factor-2 | 4 | 2013 | 17 | 0.170 |
Why?
|
RNA, Small Nuclear | 1 | 2019 | 34 | 0.170 |
Why?
|
Lung Neoplasms | 2 | 2023 | 2344 | 0.170 |
Why?
|
Blotting, Northern | 2 | 2017 | 258 | 0.170 |
Why?
|
Machine Learning | 1 | 2021 | 256 | 0.170 |
Why?
|
Ceftriaxone | 1 | 2019 | 9 | 0.170 |
Why?
|
RNA, Ribosomal, 28S | 1 | 2018 | 11 | 0.170 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 887 | 0.170 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 254 | 0.160 |
Why?
|
Anemia, Hemolytic | 1 | 2019 | 19 | 0.160 |
Why?
|
DNA Damage | 1 | 2021 | 371 | 0.160 |
Why?
|
Gene Expression | 2 | 2021 | 1310 | 0.160 |
Why?
|
Cell Differentiation | 2 | 2024 | 1521 | 0.160 |
Why?
|
CME-Carbodiimide | 1 | 2018 | 1 | 0.160 |
Why?
|
Base Composition | 4 | 2022 | 35 | 0.160 |
Why?
|
Base Pair Mismatch | 2 | 2013 | 27 | 0.160 |
Why?
|
Pyrimidines | 1 | 2021 | 372 | 0.160 |
Why?
|
Thermotoga maritima | 2 | 2010 | 15 | 0.160 |
Why?
|
Amination | 1 | 2018 | 5 | 0.160 |
Why?
|
Endoplasmic Reticulum Stress | 2 | 2022 | 85 | 0.160 |
Why?
|
Biomedical Research | 1 | 2022 | 397 | 0.150 |
Why?
|
Deafness | 2 | 2015 | 47 | 0.150 |
Why?
|
Meckel Diverticulum | 1 | 2017 | 6 | 0.150 |
Why?
|
Ribonucleases | 1 | 2018 | 93 | 0.150 |
Why?
|
Cisplatin | 1 | 2020 | 617 | 0.150 |
Why?
|
RNA Probes | 2 | 2016 | 16 | 0.150 |
Why?
|
Crystallography, X-Ray | 7 | 2021 | 486 | 0.150 |
Why?
|
Reproducibility of Results | 1 | 2024 | 2751 | 0.150 |
Why?
|
Argonaute Proteins | 1 | 2017 | 10 | 0.150 |
Why?
|
Cell Movement | 1 | 2021 | 783 | 0.150 |
Why?
|
Proteomics | 2 | 2023 | 230 | 0.150 |
Why?
|
Biocatalysis | 2 | 2015 | 50 | 0.150 |
Why?
|
Open Reading Frames | 2 | 2014 | 119 | 0.150 |
Why?
|
Demethylation | 1 | 2017 | 9 | 0.150 |
Why?
|
Nucleotides | 3 | 2017 | 97 | 0.150 |
Why?
|
Oxidation-Reduction | 4 | 2020 | 385 | 0.150 |
Why?
|
Disease | 1 | 2018 | 90 | 0.140 |
Why?
|
Firmicutes | 1 | 2017 | 15 | 0.140 |
Why?
|
AlkB Homolog 1, Histone H2a Dioxygenase | 1 | 2016 | 3 | 0.140 |
Why?
|
Printing | 1 | 2016 | 4 | 0.140 |
Why?
|
Sulfur Radioisotopes | 1 | 2016 | 21 | 0.140 |
Why?
|
Anaerobiosis | 1 | 2016 | 22 | 0.140 |
Why?
|
Carbon Radioisotopes | 1 | 2016 | 35 | 0.140 |
Why?
|
Tritium | 1 | 2016 | 133 | 0.140 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2016 | 15 | 0.140 |
Why?
|
Codon, Initiator | 2 | 2016 | 22 | 0.140 |
Why?
|
RNA Transport | 2 | 2013 | 11 | 0.140 |
Why?
|
Male | 17 | 2024 | 42147 | 0.140 |
Why?
|
Peroxides | 3 | 2020 | 12 | 0.140 |
Why?
|
Viral Proteins | 2 | 2012 | 300 | 0.140 |
Why?
|
RNA, Transfer, Glu | 1 | 2016 | 3 | 0.140 |
Why?
|
Citrate (si)-Synthase | 1 | 2015 | 2 | 0.130 |
Why?
|
Immunotherapy | 1 | 2021 | 664 | 0.130 |
Why?
|
Radioisotopes | 1 | 2016 | 45 | 0.130 |
Why?
|
Lysine | 1 | 2016 | 150 | 0.130 |
Why?
|
Mice, Nude | 2 | 2020 | 814 | 0.130 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2013 | 42 | 0.130 |
Why?
|
Thermus thermophilus | 2 | 2006 | 10 | 0.130 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 3202 | 0.130 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2024 | 470 | 0.130 |
Why?
|
Speech Intelligibility | 1 | 2015 | 10 | 0.130 |
Why?
|
Child | 7 | 2023 | 7133 | 0.130 |
Why?
|
Organophosphorus Compounds | 2 | 2011 | 55 | 0.130 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2007 | 71 | 0.130 |
Why?
|
Metals | 3 | 2023 | 92 | 0.130 |
Why?
|
Epigenomics | 1 | 2016 | 103 | 0.130 |
Why?
|
Recombinant Proteins | 3 | 2021 | 1011 | 0.130 |
Why?
|
Heat-Shock Response | 1 | 2015 | 50 | 0.120 |
Why?
|
Immunoprecipitation | 1 | 2015 | 138 | 0.120 |
Why?
|
Cross-Linking Reagents | 1 | 2015 | 87 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 338 | 0.120 |
Why?
|
Apoptosomes | 1 | 2014 | 2 | 0.120 |
Why?
|
Adenine | 1 | 2014 | 88 | 0.120 |
Why?
|
Cytochromes c | 1 | 2014 | 27 | 0.120 |
Why?
|
Genome, Insect | 1 | 2014 | 76 | 0.120 |
Why?
|
Ultraviolet Rays | 2 | 2014 | 194 | 0.120 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 751 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2023 | 8178 | 0.120 |
Why?
|
Dimerization | 2 | 2005 | 143 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2012 | 185 | 0.120 |
Why?
|
Plasmids | 2 | 2012 | 291 | 0.120 |
Why?
|
Consensus Sequence | 1 | 2013 | 65 | 0.110 |
Why?
|
Frameshifting, Ribosomal | 1 | 2013 | 5 | 0.110 |
Why?
|
Testis | 2 | 2021 | 152 | 0.110 |
Why?
|
Bothrops | 1 | 2013 | 1 | 0.110 |
Why?
|
Spleen | 2 | 2022 | 431 | 0.110 |
Why?
|
Conserved Sequence | 5 | 2017 | 211 | 0.110 |
Why?
|
Genome, Mitochondrial | 1 | 2013 | 27 | 0.110 |
Why?
|
Digestive System Neoplasms | 2 | 2004 | 21 | 0.110 |
Why?
|
Biological Evolution | 2 | 2012 | 963 | 0.110 |
Why?
|
Molecular Docking Simulation | 1 | 2013 | 48 | 0.110 |
Why?
|
Cochlear Nerve | 1 | 2013 | 9 | 0.110 |
Why?
|
Tryptophan | 2 | 2010 | 92 | 0.110 |
Why?
|
Databases, Protein | 1 | 2013 | 51 | 0.110 |
Why?
|
Retrospective Studies | 6 | 2023 | 8973 | 0.110 |
Why?
|
Vaccinia virus | 1 | 2012 | 19 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2007 | 548 | 0.110 |
Why?
|
Stem Cell Factor | 1 | 2012 | 19 | 0.110 |
Why?
|
Transcriptional Elongation Factors | 2 | 2005 | 23 | 0.110 |
Why?
|
Yeasts | 3 | 2007 | 49 | 0.110 |
Why?
|
Ferrous Compounds | 3 | 1998 | 17 | 0.110 |
Why?
|
Fungal Proteins | 1 | 2013 | 141 | 0.110 |
Why?
|
Erythroid Precursor Cells | 1 | 2012 | 33 | 0.110 |
Why?
|
Edetic Acid | 3 | 1998 | 42 | 0.110 |
Why?
|
RNA, Transfer, Leu | 1 | 2012 | 11 | 0.110 |
Why?
|
Nanotechnology | 1 | 2013 | 68 | 0.100 |
Why?
|
Erythropoietin | 1 | 2012 | 88 | 0.100 |
Why?
|
Cobamides | 1 | 2012 | 2 | 0.100 |
Why?
|
RNA Polymerase I | 1 | 2012 | 3 | 0.100 |
Why?
|
Forecasting | 1 | 2013 | 305 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2018 | 754 | 0.100 |
Why?
|
Gastrectomy | 1 | 2012 | 69 | 0.100 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2012 | 91 | 0.100 |
Why?
|
Influenza A virus | 1 | 2012 | 169 | 0.100 |
Why?
|
Female | 13 | 2024 | 45912 | 0.100 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2012 | 173 | 0.100 |
Why?
|
Osmolar Concentration | 1 | 2012 | 181 | 0.100 |
Why?
|
Iron | 2 | 2024 | 165 | 0.100 |
Why?
|
Diethyl Pyrocarbonate | 2 | 2001 | 5 | 0.100 |
Why?
|
Protein Subunits | 2 | 2002 | 123 | 0.100 |
Why?
|
Digestive System Surgical Procedures | 2 | 2004 | 126 | 0.100 |
Why?
|
Genes, Reporter | 2 | 2009 | 274 | 0.100 |
Why?
|
Siloxanes | 1 | 2011 | 5 | 0.100 |
Why?
|
Styrenes | 1 | 2011 | 7 | 0.100 |
Why?
|
Tympanoplasty | 2 | 2021 | 13 | 0.100 |
Why?
|
RNA Splicing | 1 | 2013 | 152 | 0.100 |
Why?
|
Geobacillus stearothermophilus | 3 | 2008 | 10 | 0.100 |
Why?
|
Green Fluorescent Proteins | 2 | 2009 | 309 | 0.100 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2012 | 200 | 0.100 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2012 | 153 | 0.090 |
Why?
|
DNA Repair Enzymes | 1 | 2011 | 55 | 0.090 |
Why?
|
Antigen Presentation | 1 | 2012 | 215 | 0.090 |
Why?
|
Uridine | 1 | 2010 | 56 | 0.090 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2004 | 127 | 0.090 |
Why?
|
Nucleic Acid Heteroduplexes | 2 | 2001 | 11 | 0.090 |
Why?
|
Transfection | 1 | 2012 | 911 | 0.090 |
Why?
|
Primary Cell Culture | 2 | 2021 | 76 | 0.090 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 666 | 0.090 |
Why?
|
Cytosine | 1 | 2011 | 128 | 0.090 |
Why?
|
Spectrometry, Fluorescence | 4 | 2005 | 85 | 0.090 |
Why?
|
Selection, Genetic | 2 | 2014 | 509 | 0.090 |
Why?
|
Infant | 4 | 2021 | 3138 | 0.090 |
Why?
|
Ribonuclease T1 | 2 | 1999 | 7 | 0.090 |
Why?
|
Arginine | 1 | 2010 | 138 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2013 | 366 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2550 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2009 | 37 | 0.090 |
Why?
|
Cryoelectron Microscopy | 1 | 2010 | 95 | 0.090 |
Why?
|
Nitrogen | 1 | 2010 | 73 | 0.090 |
Why?
|
Child, Preschool | 4 | 2021 | 3704 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 2410 | 0.090 |
Why?
|
Orthomyxoviridae | 1 | 2009 | 36 | 0.090 |
Why?
|
Laparoscopy | 2 | 2017 | 771 | 0.090 |
Why?
|
Transcriptional Activation | 2 | 2013 | 291 | 0.090 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 403 | 0.080 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 1086 | 0.080 |
Why?
|
NADPH Oxidases | 1 | 2009 | 82 | 0.080 |
Why?
|
eIF-2 Kinase | 1 | 2009 | 48 | 0.080 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 394 | 0.080 |
Why?
|
Bortezomib | 1 | 2009 | 82 | 0.080 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 92 | 0.080 |
Why?
|
ErbB Receptors | 2 | 2023 | 500 | 0.080 |
Why?
|
Sensitivity and Specificity | 4 | 2007 | 2013 | 0.080 |
Why?
|
Hot Temperature | 2 | 2002 | 208 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2000 | 499 | 0.080 |
Why?
|
Protons | 2 | 1999 | 101 | 0.080 |
Why?
|
Adenoviridae | 1 | 2009 | 349 | 0.080 |
Why?
|
Ligands | 1 | 2009 | 443 | 0.080 |
Why?
|
Hydrogen Bonding | 3 | 2004 | 144 | 0.080 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2008 | 95 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 387 | 0.080 |
Why?
|
Breast | 1 | 2009 | 292 | 0.070 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2007 | 11 | 0.070 |
Why?
|
Vulva | 1 | 2006 | 23 | 0.070 |
Why?
|
Nucleic Acid Denaturation | 3 | 2001 | 34 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2021 | 2879 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2006 | 122 | 0.070 |
Why?
|
Evaluation Studies as Topic | 1 | 2006 | 270 | 0.070 |
Why?
|
Species Specificity | 3 | 2013 | 684 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 193 | 0.070 |
Why?
|
Endopeptidase K | 1 | 2005 | 12 | 0.070 |
Why?
|
Gene Dosage | 1 | 2006 | 208 | 0.070 |
Why?
|
Lymphatic Metastasis | 2 | 2007 | 502 | 0.070 |
Why?
|
DNA Primers | 2 | 1998 | 543 | 0.070 |
Why?
|
Molecular Motor Proteins | 1 | 2006 | 31 | 0.070 |
Why?
|
Thymus Gland | 1 | 2006 | 197 | 0.070 |
Why?
|
Dogs | 1 | 2006 | 704 | 0.060 |
Why?
|
Molecular Weight | 1 | 2005 | 331 | 0.060 |
Why?
|
Scattering, Radiation | 2 | 2002 | 116 | 0.060 |
Why?
|
X-Rays | 2 | 2002 | 133 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 557 | 0.060 |
Why?
|
Polyribosomes | 2 | 2016 | 20 | 0.060 |
Why?
|
PrPC Proteins | 1 | 2005 | 13 | 0.060 |
Why?
|
Computer Simulation | 2 | 2007 | 1096 | 0.060 |
Why?
|
Obesity | 1 | 2011 | 964 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 1174 | 0.060 |
Why?
|
Metal Nanoparticles | 1 | 2024 | 31 | 0.060 |
Why?
|
Cloning, Molecular | 2 | 1996 | 646 | 0.060 |
Why?
|
Molecular Structure | 2 | 2019 | 288 | 0.060 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 247 | 0.060 |
Why?
|
Rifampin | 1 | 2004 | 23 | 0.060 |
Why?
|
Sodium Chloride | 2 | 2009 | 87 | 0.060 |
Why?
|
Phospholipase C gamma | 1 | 2023 | 15 | 0.060 |
Why?
|
Indole Alkaloids | 1 | 2023 | 3 | 0.060 |
Why?
|
Synthetic Biology | 1 | 2023 | 15 | 0.060 |
Why?
|
Phenotype | 1 | 2010 | 2439 | 0.060 |
Why?
|
Erlotinib Hydrochloride | 1 | 2023 | 90 | 0.060 |
Why?
|
Oligoribonucleotides | 2 | 2017 | 28 | 0.060 |
Why?
|
Fruit | 1 | 2023 | 76 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2023 | 123 | 0.050 |
Why?
|
Oceans and Seas | 1 | 2023 | 30 | 0.050 |
Why?
|
Receptors, KIR2DL1 | 1 | 2022 | 3 | 0.050 |
Why?
|
Fusobacterium nucleatum | 1 | 2022 | 4 | 0.050 |
Why?
|
Endosonography | 1 | 2023 | 98 | 0.050 |
Why?
|
Organic Chemicals | 1 | 2023 | 34 | 0.050 |
Why?
|
Muscle Contraction | 1 | 2004 | 284 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2023 | 30 | 0.050 |
Why?
|
Drainage | 1 | 2023 | 161 | 0.050 |
Why?
|
Cochlea | 1 | 2023 | 50 | 0.050 |
Why?
|
Thyrotropin | 1 | 2024 | 286 | 0.050 |
Why?
|
Replantation | 1 | 2023 | 36 | 0.050 |
Why?
|
Hyperplasia | 1 | 2023 | 152 | 0.050 |
Why?
|
Tetrahymena | 1 | 2002 | 37 | 0.050 |
Why?
|
Sulfites | 1 | 2022 | 31 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 921 | 0.050 |
Why?
|
Triiodothyronine | 1 | 2024 | 341 | 0.050 |
Why?
|
Thyroxine | 1 | 2024 | 347 | 0.050 |
Why?
|
Protein Interaction Maps | 1 | 2022 | 49 | 0.050 |
Why?
|
Oncogenes | 1 | 2022 | 92 | 0.050 |
Why?
|
Evoked Potentials, Auditory | 1 | 2022 | 37 | 0.050 |
Why?
|
Manubrium | 1 | 2021 | 1 | 0.050 |
Why?
|
Tensor Tympani | 1 | 2021 | 1 | 0.050 |
Why?
|
Malleus | 1 | 2021 | 4 | 0.050 |
Why?
|
Heparin | 1 | 2023 | 185 | 0.050 |
Why?
|
CLOCK Proteins | 1 | 2021 | 15 | 0.050 |
Why?
|
Apolipoproteins | 1 | 2021 | 35 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2022 | 159 | 0.050 |
Why?
|
Liver | 1 | 2006 | 1204 | 0.050 |
Why?
|
Tendons | 1 | 2021 | 44 | 0.050 |
Why?
|
Cytidine | 1 | 2021 | 17 | 0.050 |
Why?
|
Speech | 1 | 2022 | 85 | 0.050 |
Why?
|
Immunity | 1 | 2022 | 141 | 0.050 |
Why?
|
RNA Ligase (ATP) | 1 | 2001 | 3 | 0.050 |
Why?
|
Nucleic Acid Renaturation | 1 | 2001 | 5 | 0.050 |
Why?
|
Exonucleases | 1 | 2001 | 8 | 0.050 |
Why?
|
Phosphorus Radioisotopes | 1 | 2001 | 19 | 0.050 |
Why?
|
Hep G2 Cells | 1 | 2021 | 48 | 0.050 |
Why?
|
Plant Extracts | 1 | 2023 | 244 | 0.050 |
Why?
|
Cations, Monovalent | 1 | 2001 | 6 | 0.050 |
Why?
|
Cations, Divalent | 1 | 2001 | 39 | 0.050 |
Why?
|
Avidin | 1 | 2001 | 5 | 0.050 |
Why?
|
Deuterium Exchange Measurement | 1 | 2021 | 10 | 0.050 |
Why?
|
Hearing | 1 | 2021 | 59 | 0.050 |
Why?
|
Muscles | 1 | 2021 | 193 | 0.050 |
Why?
|
Scattering, Small Angle | 1 | 2021 | 35 | 0.050 |
Why?
|
Cell Survival | 2 | 2014 | 981 | 0.050 |
Why?
|
Chromatography, Gel | 1 | 2001 | 103 | 0.050 |
Why?
|
Genes, Bacterial | 2 | 2012 | 198 | 0.050 |
Why?
|
Biotin | 1 | 2001 | 45 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2001 | 177 | 0.050 |
Why?
|
Mastoid | 1 | 2021 | 17 | 0.050 |
Why?
|
Ear Canal | 1 | 2021 | 16 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 645 | 0.050 |
Why?
|
Stents | 1 | 2023 | 395 | 0.050 |
Why?
|
Prognosis | 2 | 2022 | 3757 | 0.050 |
Why?
|
Hemorrhage | 1 | 2023 | 278 | 0.050 |
Why?
|
Cattle | 1 | 2001 | 375 | 0.050 |
Why?
|
Protein Domains | 1 | 2021 | 133 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 1708 | 0.050 |
Why?
|
Threonine | 1 | 2020 | 35 | 0.050 |
Why?
|
Reoperation | 1 | 2023 | 598 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 858 | 0.040 |
Why?
|
Titrimetry | 1 | 1999 | 15 | 0.040 |
Why?
|
Rats | 1 | 2006 | 4039 | 0.040 |
Why?
|
Time Factors | 4 | 2012 | 5313 | 0.040 |
Why?
|
Tyrosine-tRNA Ligase | 1 | 2019 | 1 | 0.040 |
Why?
|
Virion | 1 | 2020 | 59 | 0.040 |
Why?
|
Gain of Function Mutation | 1 | 2019 | 13 | 0.040 |
Why?
|
Drug Synergism | 1 | 2020 | 305 | 0.040 |
Why?
|
Bacteriophage T7 | 1 | 1999 | 7 | 0.040 |
Why?
|
Hydroxides | 1 | 1999 | 9 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 866 | 0.040 |
Why?
|
Anticoagulants | 1 | 2023 | 426 | 0.040 |
Why?
|
Vertebrates | 1 | 2020 | 103 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 116 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2019 | 57 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 164 | 0.040 |
Why?
|
Vestibular Aqueduct | 1 | 2019 | 2 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 1399 | 0.040 |
Why?
|
MERRF Syndrome | 1 | 2018 | 2 | 0.040 |
Why?
|
DNA Footprinting | 1 | 1998 | 18 | 0.040 |
Why?
|
Lymphocytes | 1 | 2021 | 471 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2013 | 833 | 0.040 |
Why?
|
Myoblasts | 1 | 2018 | 32 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 592 | 0.040 |
Why?
|
Axons | 1 | 2019 | 179 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2021 | 304 | 0.040 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2019 | 47 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 1699 | 0.040 |
Why?
|
T-Lymphocytes | 2 | 2017 | 1222 | 0.040 |
Why?
|
Magnesium Chloride | 1 | 1997 | 6 | 0.040 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1997 | 44 | 0.040 |
Why?
|
Exons | 1 | 2019 | 451 | 0.040 |
Why?
|
Laparotomy | 1 | 2017 | 67 | 0.040 |
Why?
|
Protein Denaturation | 1 | 1997 | 106 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2012 | 565 | 0.040 |
Why?
|
RNA, Transfer, Arg | 1 | 2017 | 2 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 1998 | 242 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2017 | 10 | 0.040 |
Why?
|
Esters | 1 | 1997 | 29 | 0.040 |
Why?
|
Protein Splicing | 1 | 2017 | 2 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2017 | 68 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2024 | 2347 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 442 | 0.040 |
Why?
|
Carbon | 1 | 1997 | 90 | 0.040 |
Why?
|
Butadienes | 1 | 2016 | 34 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2022 | 1265 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2004 | 1194 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 520 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2020 | 474 | 0.030 |
Why?
|
GC Rich Sequence | 1 | 2016 | 8 | 0.030 |
Why?
|
Eubacterium | 1 | 1995 | 2 | 0.030 |
Why?
|
Models, Structural | 1 | 1995 | 58 | 0.030 |
Why?
|
RNA Interference | 1 | 2017 | 376 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2016 | 57 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2015 | 35 | 0.030 |
Why?
|
Cycloheximide | 1 | 2015 | 56 | 0.030 |
Why?
|
Nitriles | 1 | 2016 | 160 | 0.030 |
Why?
|
Protein Aggregates | 1 | 2015 | 21 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 275 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 2015 | 96 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 465 | 0.030 |
Why?
|
Thiourea | 1 | 2014 | 8 | 0.030 |
Why?
|
Potassium Chloride | 1 | 1995 | 86 | 0.030 |
Why?
|
Point Mutation | 1 | 1995 | 245 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 75 | 0.030 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2014 | 7 | 0.030 |
Why?
|
Osmotic Pressure | 1 | 2014 | 21 | 0.030 |
Why?
|
Caspase 9 | 1 | 2014 | 49 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2014 | 73 | 0.030 |
Why?
|
Caspase 3 | 1 | 2014 | 161 | 0.030 |
Why?
|
RNA 3' End Processing | 1 | 2013 | 1 | 0.030 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2013 | 39 | 0.030 |
Why?
|
RNA Nucleotidyltransferases | 1 | 2013 | 12 | 0.030 |
Why?
|
Glucose | 1 | 2016 | 628 | 0.030 |
Why?
|
Amino Acid Transport Systems | 1 | 2013 | 4 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2005 | 1938 | 0.030 |
Why?
|
Activating Transcription Factor 4 | 1 | 2013 | 15 | 0.030 |
Why?
|
Organelles | 1 | 2013 | 56 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 1590 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2013 | 17 | 0.030 |
Why?
|
Arsenites | 1 | 2012 | 6 | 0.030 |
Why?
|
Hypertonic Solutions | 1 | 2012 | 17 | 0.030 |
Why?
|
Glutamate-tRNA Ligase | 1 | 2012 | 1 | 0.030 |
Why?
|
Virus Integration | 1 | 2012 | 16 | 0.030 |
Why?
|
Genes, Viral | 1 | 2012 | 117 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 46 | 0.030 |
Why?
|
Antibodies | 1 | 2014 | 353 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2013 | 187 | 0.030 |
Why?
|
Hybridomas | 1 | 2012 | 75 | 0.030 |
Why?
|
Middle Aged | 4 | 2024 | 25787 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2012 | 144 | 0.030 |
Why?
|
COS Cells | 1 | 2012 | 167 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2013 | 172 | 0.030 |
Why?
|
Nanostructures | 1 | 2013 | 78 | 0.030 |
Why?
|
Adult | 4 | 2024 | 26440 | 0.030 |
Why?
|
Archaea | 1 | 2012 | 18 | 0.030 |
Why?
|
Aged | 3 | 2024 | 19019 | 0.030 |
Why?
|
Eukaryota | 1 | 2012 | 45 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2012 | 141 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 267 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2017 | 2469 | 0.020 |
Why?
|
AlkB Homolog 8, tRNA Methyltransferase | 1 | 2010 | 2 | 0.020 |
Why?
|
Hydroxylation | 1 | 2010 | 17 | 0.020 |
Why?
|
Bacillus | 1 | 2010 | 12 | 0.020 |
Why?
|
Environment | 1 | 2012 | 224 | 0.020 |
Why?
|
Fibroblasts | 1 | 2014 | 755 | 0.020 |
Why?
|
HIV Infections | 1 | 2020 | 830 | 0.020 |
Why?
|
Recovery of Function | 1 | 2012 | 292 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2010 | 96 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 381 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2017 | 3649 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 684 | 0.020 |
Why?
|
Protein Phosphatase 2 | 1 | 2010 | 16 | 0.020 |
Why?
|
RNA, Transfer, Asn | 1 | 2009 | 1 | 0.020 |
Why?
|
RNA, Transfer, Ile | 1 | 2009 | 1 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 27 | 0.020 |
Why?
|
Static Electricity | 1 | 2010 | 90 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2014 | 606 | 0.020 |
Why?
|
DNA Probes | 1 | 2009 | 77 | 0.020 |
Why?
|
Virus Assembly | 1 | 2009 | 21 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 85 | 0.020 |
Why?
|
Leucine | 1 | 2009 | 60 | 0.020 |
Why?
|
Adenosine Monophosphate | 1 | 2009 | 27 | 0.020 |
Why?
|
Survival Rate | 1 | 2013 | 1881 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 273 | 0.020 |
Why?
|
DNA Repair | 1 | 2010 | 361 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2012 | 1573 | 0.020 |
Why?
|
DNA Ligases | 1 | 2007 | 13 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2007 | 63 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 1241 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2007 | 221 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2007 | 698 | 0.020 |
Why?
|
Drug Resistance, Multiple | 1 | 2005 | 20 | 0.020 |
Why?
|
Neurons | 1 | 2014 | 1576 | 0.020 |
Why?
|
Escherichia coli K12 | 1 | 2005 | 4 | 0.020 |
Why?
|
Spliceosomes | 1 | 2005 | 48 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 9214 | 0.020 |
Why?
|
Ribonucleotides | 1 | 2004 | 13 | 0.020 |
Why?
|
Risk Assessment | 1 | 2012 | 2286 | 0.020 |
Why?
|
Intestine, Large | 1 | 2004 | 15 | 0.010 |
Why?
|
Rosaniline Dyes | 1 | 2004 | 9 | 0.010 |
Why?
|
Culture Techniques | 1 | 2004 | 91 | 0.010 |
Why?
|
Energy Transfer | 1 | 2004 | 25 | 0.010 |
Why?
|
Fluorescence | 1 | 2004 | 103 | 0.010 |
Why?
|
Esophagus | 1 | 2004 | 106 | 0.010 |
Why?
|
Stomach | 1 | 2004 | 111 | 0.010 |
Why?
|
Cell Cycle | 1 | 2005 | 509 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2004 | 354 | 0.010 |
Why?
|
Intestine, Small | 1 | 2004 | 299 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2012 | 2273 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 956 | 0.010 |
Why?
|
Risk Factors | 1 | 2012 | 5453 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 3370 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 575 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2004 | 778 | 0.010 |
Why?
|
Enzyme Stability | 1 | 2001 | 39 | 0.010 |
Why?
|
Synchrotrons | 1 | 2000 | 28 | 0.010 |
Why?
|
Solutions | 1 | 2000 | 85 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 1848 | 0.010 |
Why?
|
RNA, Protozoan | 1 | 1999 | 5 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 4259 | 0.010 |
Why?
|